TNFRSF9 and cancer: The chimeric antigen receptor (CAR) structure consists of a single-chain variable fragment derived from a monoclonal antibody targeting a cancer-specific antigen, intracellular segment, signaling domain derived from TCR, and one or more co-stimulatory sequences (CD28, OX40, or 4-1BB) [175].